Trader Note — 9238 total
WillScot Holdings enters the week before its August 3 earnings in an unusual position: a fresh analyst upgrade arrived the same day the stock fell 3% to $25.67, capping an 11% weekly decline that has pushed the shares…
Lemonade heads into its July 29 earnings with a sharp analyst downgrade landing on the same day the stock trades 50% above where it was just one month ago. The most significant development this week is Morgan Stanley's…
CMPS heads into the week of July 8 with a wave of bullish analyst action reshaping the Street narrative — even as the stock pulls back 8% on the week and earnings loom on July 30. The analyst story is the standout this…
KC enters the week with a rare combination: a fresh Morgan Stanley initiation on the bull side and a borrow market that has been running near capacity for over a month. The most significant development this week is the…
Accel Entertainment enters its July 30 earnings print with a quiet but persistent build in short positions and a cluster of insider sales that together create a more cautious backdrop than the modestly positive monthly…
Definium Therapeutics has pulled back 5.4% this week to $44.48, giving back a slice of the 89% one-month gain that followed its June 22 Phase 3 data release — and the question now is whether the defensive posture…
Arcutis Biotherapeutics has climbed 30% in a month and nearly 6% in a week, yet nearly 13% of the float remains short — a setup where the stock's momentum and its skeptics are heading in opposite directions ahead of a…
Betterware de México heads into its July 23 Q2 earnings report with the Street uniformly constructive, the borrow market loose, and a historically painful pattern from last quarter still fresh. The earnings setup is…
BWIN enters the back half of the year with an unusual tension at its core: a 37% one-month rally that has pulled shorts back and flipped options sentiment decisively bullish, yet the stock still carries 18% of its…
Beam Therapeutics enters the second week of July with a sharp price rally colliding head-on with one of the heaviest short positions in the gene-editing space. The stock closed at $37.92 on Tuesday, up 10.5% on the…
Revolution Medicines is trading at $190.46 — up 28% over the past month and now within touching distance of the Street's mean price target — creating a fresh question about whether the re-rating has run its course or…
BNTX heads into the week with a fresh analyst target cut from its most prominent sell-side backer — yet the options market is, unusually, leaning more bullish than it has in months. Morgan Stanley's Terence Flynn…
10x Genomics sits in a rare and uncomfortable spot — the Street is rushing to lift price targets while short interest continues to grind higher, and the stock fell 5.4% on Tuesday to $37.83, still below where most of…
Kura Sushi USA has delivered its earnings print — and the Street's response has been a wave of target cuts, sending the stock down 8% on the week to $52.90. The analyst reaction is the clearest signal this week. Every…
CrowdStrike enters the second week of July with a genuinely unusual combination: short interest climbing at its fastest pace in months, a Street that remains broadly bullish but is rapidly resetting price targets…
Parsons Corporation heads into its July 29 earnings with an unusual setup: insiders spent May buying aggressively into weakness while short sellers have been steadily rebuilding positions through June and into…
Palomar Holdings enters the week of July 8 having just posted one of its sharpest short-term rallies in recent memory — up 15% on the week and 34% over the past month — while the Street's most active analyst raises his…
PINS heads into its August 4 earnings with short sellers quietly trimming positions and two analyst actions this week pointing in the same direction — up. The positioning picture has shifted meaningfully over the past…
LEVI has reported Q2 2026 results, and the week's most interesting question is how the dust settles — shorts have already covered aggressively into the print, analysts raised targets in unison beforehand, yet the stock…
LYFT has climbed 5.7% over the past week to $15.44, yet short sellers are simultaneously adding to positions — a divergence that sets up an interesting tension heading into the August 7 earnings print. The short side…
